Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray

Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray

[PR Newswire] – DUBLIN, May 12, 2014 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for azelastine hydroc more

View todays social media effects on PRGO

View the latest stocks trending across Twitter. Click to view dashboard

See who Perrigo is hiring next, click here to view

Share this post